SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001104659-24-059467
Filing Date
2024-05-10
Accepted
2024-05-09 17:33:53
Documents
4
Period of Report
2024-05-09

Document Format Files

Seq Description Document Type Size
1 PRE 14A tm243024d1_pre14a.htm PRE 14A 3038641
2 GRAPHIC tm243024d1_pre14aimg001.jpg GRAPHIC 12505
3 GRAPHIC tm243024d1_pre14aimg002.jpg GRAPHIC 27542
4 GRAPHIC tm243024d1_pre14aimg003.jpg GRAPHIC 35807
  Complete submission text file 0001104659-24-059467.txt   3144852
Mailing Address 777 YAMATO ROAD SUITE 502 BOCA RATON FL 33431
Business Address 777 YAMATO ROAD SUITE 502 BOCA RATON FL 33431 561-589-7020
First Wave BioPharma, Inc. (Filer) CIK: 0001604191 (see all company filings)

IRS No.: 464993860 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-37853 | Film No.: 24932105
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)